Skip to main content

Congestive Heart Failure News (Page 3)

Serious Complications Seen With Acetaminophen Use in Seniors

TUESDAY, Dec. 17, 2024 – In older adults, acetaminophen use is associated with serious complications, according to a study published online Nov. 24 in Arthritis Care & Research. Jaspreet Kaur,...

Gene Therapy Reverses Heart Failure in Pig Trials

TUESDAY, Dec. 10, 2024 – Failing hearts nearly returned to full function in laboratory pigs after they received an experimental gene therapy. New research shows the gene therapy didn’t just prevent h...

There's a 'Sweet Spot' for Daily Sugar Intake & Heart Health

MONDAY, Dec. 9, 2024 – When it comes to sweets, the type a person chooses can have a significant impact on their heart health, a new study finds. Sugary drinks significantly increase a person’s risk ...

American Heart Association, Nov. 16-18

The annual meeting of the American Heart Association was held this year from Nov. 16 to 18 in Chicago, drawing attendees from around the world, including cardiovascular specialists, surgeons, and n...

AHA: Variation Seen in Rates of SGLT2i Rx for Heart Failure, LVEF >40 Percent

TUESDAY, Nov. 26, 2024 – From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for patients with heart failure and a left ventricular...

Heart Failure With Preserved Ejection Fraction Underdiagnosed

MONDAY, Nov. 25, 2024 – Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology (isolated STR),...

AHA: Tirzepatide Beneficial for Heart Failure With Preserved EF, Obesity

FRIDAY, Nov. 22, 2024 – For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes or worsening heart...

Weight-Loss Drug Zepbound May Lower Heart Failure Deaths

THURSDAY, Nov. 21, 2024 – A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand...

A-fib Plus Heart Failure a Dangerous Combo

WEDNESDAY, Nov. 20, 2024 – For the 4 in 10 patients with newly diagnosed heart failure who also have the heart rhythm disorder atrial fibrillation, the prognosis can be poor. "Atrial fibrillation...

Palliative Care Use Low in Patients With Heart Failure

WEDNESDAY, Nov. 13, 2024 – Use of palliative care for heart failure remains low in the United States, according to a study recently published online in the Journal of the American Heart Association. ...

Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression

TUESDAY, Nov. 12, 2024 – Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors...

Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF

WEDNESDAY, Oct. 16, 2024 – For individuals with heart failure with reduced ejection fraction (HFrEF), substantial mortality benefits would result from optimal use of guideline-directed medical...

About 6.7 Million Americans Older Than 20 Years Have Heart Failure

WEDNESDAY, Oct. 2, 2024 – About 6.7 million Americans older than age 20 years have heart failure, according to an updated report from the Heart Failure Society of America published online Sept. 24...

Event-Free Survival Extended With Long-Term Finerenone in Heart Failure

MONDAY, Sept. 30, 2024 – Long-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according...

Endovascular Therapy Improves Left Ventricular Diastolic Function in HFpEF

FRIDAY, Sept. 20, 2024 – For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ventricular (LV) diastolic function, according to a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Left Ventricular Dysfunction, Cardiovascular Conditions and Disorders

Related drug support groups

lisinopril, metoprolol, warfarin, spironolactone, Coumadin, triamcinolone, carvedilol, Metoprolol Succinate ER, diltiazem, view more... Lasix, furosemide, Entresto, bisoprolol, valsartan, Farxiga, Jardiance, ramipril, digoxin, prazosin, Diovan, nitroglycerin, Coreg